Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone (GHRH 1-44), incorporating an N-terminal trans-3-hexenoic acid modification that enhances research stability against enzymatic degradation. With a molecular weight of approximately 5,135.9 Da, it was first described in published endocrine research literature in the early 2000s. Tesamorelin is studied in research models that investigate GHRH receptor pathway signaling, somatotropic axis function, and lipodystrophy-relevant metabolic pathways. Also referenced as TH9507, Egrifta, or Tesamorelin 10mg, it is supplied as a lyophilized powder for laboratory reference use. Triumphant Labs Tesamorelin is provided strictly for in vitro research applications and is not approved for human or animal use.

DISCLAIMER: By purchasing from Triumphant Labs you agree that you are purchasing Research Chemicals which are in no way intended for use in humans.

Triumphant Labs products are furnished for LABORATORY RESEARCH USE ONLY. This product should only be handled by qualified, and licensed professionals. The product may not be used as a drug, agricultural or pesticidal product, food additive or household chemical – and may not be misbranded as such. Bodily introduction of any kind into humans and/or animals is strictly forbidden by law.

Research Chemicals ARE NOT DIETARY SUPPLEMENTS OR PRESCRIPTION MEDICATIONS THEY ARE *RESEARCH CHEMICALS.

*Research chemicals are chemical substances used by scientists for medical and scientific research purposes. One characteristic of a research chemical is that it is for laboratory research use only; a research chemical is not intended for human or veterinary use. This distinction is required on the labels of research chemicals, and is what exempts them from regulation under parts 100-740 in Title 21 of the Code of Federal Regulations (21CFR).